Technical Analysis for GWPH - GW Pharmaceuticals Plc

Grade Last Price % Change Price Change
grade D 167.66 -2.78% -4.79
GWPH closed down 2.78 percent on Monday, July 15, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical GWPH trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -2.78%
Bollinger Band Squeeze Range Contraction -2.78%
NR7 Range Contraction -2.78%
Multiple of Ten Bullish Other -2.78%

Older signals for GWPH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain. In addition, the company has two product candidates in Phase II trials in the field of diabetes and inflammation, as well as pre-clinical research programmes evaluating the use of selected cannabinoids for the treatment of glioma, epilepsy, and psychiatric illness. It has a strategic alliance with Otsuka Pharmaceutical Co. Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.
Health Cancer Pharmaceutical Industry Pain Drugs Diabetes Medication Treatment Of Cancer Inflammation Pharmaceutical Industry In China Pharmaceuticals Policy Cannabis Epilepsy Glioma Cannabinoids Neuropathic Pain
Is GWPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 196.0
52 Week Low 90.14
Average Volume 380,722
200-Day Moving Average 152.3952
50-Day Moving Average 176.292
20-Day Moving Average 172.829
10-Day Moving Average 172.966
Average True Range 5.4523
ADX 10.08
+DI 22.2953
-DI 24.3754
Chandelier Exit (Long, 3 ATRs ) 164.3931
Chandelier Exit (Short, 3 ATRs ) 180.9769
Upper Bollinger Band 177.9039
Lower Bollinger Band 167.7541
Percent B (%b) -0.01
BandWidth 5.872741
MACD Line -0.8356
MACD Signal Line -0.6638
MACD Histogram -0.1719
Fundamentals Value
Market Cap 4.25 Billion
Num Shares 25.4 Million
EPS -5.64
Price-to-Earnings (P/E) Ratio -29.73
Price-to-Sales 253.36
Price-to-Book 6.23
PEG Ratio 0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 174.04
Resistance 3 (R3) 174.51 172.86 172.97
Resistance 2 (R2) 172.86 171.24 172.62 172.62
Resistance 1 (R1) 170.26 170.23 169.44 169.79 172.26
Pivot Point 168.61 168.61 168.20 168.37 168.61
Support 1 (S1) 166.01 166.99 165.19 165.54 163.06
Support 2 (S2) 164.36 165.98 164.12 162.70
Support 3 (S3) 161.76 164.36 162.35
Support 4 (S4) 161.29